Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 23.9.2019Accord Healthcare S.L.U (ACC-ES)1082APioglitazone Accord 45 mg tablety (tbl 28x45 mg (blis.Al/Al))31.10.2019R
 23.9.2019Accord Healthcare Polska Sp. z o.o. (AOK)5715ACytarabine Accord 100 mg/ml injekčný a infúzny roztok (sol ijf 1x1 ml (liek.inj.skl.))15.10.2019R
 23.9.2019Bayer AG (BYE-4)66195Yadine (tbl flm 1x21 (blis.Al/PVC))31.10.2019Z
 23.9.2019Bayer AG (BYE-4)66195Yadine (tbl flm 1x21 (blis.Al/PVC))31.10.2019R
 23.9.2019Mylan Ireland Limited (MNY)0877APerindopril Mylan 4 mg (tbl 30x4 mg (blis.Al/OPA/PVC/Al))24.9.2019O
 23.9.2019Viatris Limited (VIM)47776Ropinirol Viatris 2 mg (tbl flm 84x2 mg (obal HDPE))24.9.2019O
 23.9.2019Viatris Limited (VIM)08259Vancomycin Mylan 1 000 mg (plv ifo 1x1000 mg (liek.inj.skl.))24.9.2019O
 23.9.2019Mylan Pharmaceuticals Limited (MLB-IE-1)5418BPregabalin Mylan 150 mg tvrdé kapsuly (cps dur 56x150 mg (blis.PVC/PVDC/Al))24.9.2019O
 23.9.2019UNIMED PHARMA, spol. s r.o. (XUN-1)33178JODID DRASELNÝ 2 % UNIMED PHARMA (int opo 1x10 ml (fľ.PE))23.9.2019O
 23.9.2019UNIMED PHARMA, spol. s r.o. (XUN-1)33187UNICLOPHEN 0,1 % (int opo 1x10 ml (fľa. PE))23.9.2019O
 23.9.2019UNIMED PHARMA, spol. s r.o. (XUN-1)33226JODID DRASELNÝ A SODNÝ 2 % UNIMED PHARMA (int opo 1x10 ml (fľ.PE))23.9.2019O
 23.9.2019UNIMED PHARMA, spol. s r.o. (XUN-1)33230UNIDEXA 0,1 % (int opo 1x10 ml (PE))23.9.2019O
 23.9.2019UNIMED PHARMA, spol. s r.o. (XUN-1)93319FENEFRIN 10 % (int opo 1x10 ml (fľ.PE))23.9.2019O
 23.9.2019B.Braun Melsungen AG (BME)33835Hydrogenuhličitan sodný B. Braun 8,4 % (sol inf 10x250 ml (fľ.skl.))20.9.2019R
 20.9.2019Sandoz Pharmaceuticals d.d. (SAN-SLO-1)24108RANITAL 300 mg (tbl flm 30x300 mg (blis.Al/Al))20.9.2019R

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To